Actively Recruiting

Phase Not Applicable
Age: 18Years - 110Years
All Genders
NCT06473480

Continuous Bloodsugar Monitoring System With a Sensor Compared to Fingerstick Bloodsugar Monitoring

Led by Odense University Hospital · Updated on 2025-04-03

329

Participants Needed

2

Research Sites

79 weeks

Total Duration

On this page

Sponsors

O

Odense University Hospital

Lead Sponsor

Z

Zealand University Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

This clinical trial aims to compare a continuous glucose monitoring system with traditional fingerstick blood glucose monitoring. The study focuses on adult patients in general surgical wards who need regular blood glucose checks due to the risk of low or high blood sugar levels. The goal is to learn if using a continuous glucose monitoring system is better than fingerstick monitoring in managing glucose levels, preventing complications, improving patient satisfaction and experience, reducing nursing staff workload, and improving nursing staff' experience. The study also compares the accuracy of glucose readings from the continuous glucose monitoring system with those from fingerstick tests and blood samples. The hypothesis is that CGMS is accurate and effective for monitoring glucose levels in surgical patients. This could lead to better blood sugar control, fewer complications, shorter hospital stays, and improved experiences for both patients and nursing staff.

CONDITIONS

Official Title

Continuous Bloodsugar Monitoring System With a Sensor Compared to Fingerstick Bloodsugar Monitoring

Who Can Participate

Age: 18Years - 110Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Hospitalized patients 18 years or older in surgical wards
  • Required glucose measurements at least 4 times daily (OUH) or 3 times daily (SUH) for at least three days as prescribed by a surgeon
  • Expected hospital stay of at least three days
  • Able to communicate in Danish
  • Signed informed consent for study participation
  • At risk of low or high blood sugar levels, with or without a diabetes diagnosis
  • For substudy 4: Patients treated with insulin at discharge and residing within the OUH admission area
Not Eligible

You will not qualify if you...

  • Cognitive impairment
  • Glucose monitoring needed only due to parenteral nutrition
  • Already admitted using a continuous glucose monitoring system
  • Patients in the fingerstick glucose monitoring group cannot join the continuous glucose monitoring group
  • For substudy 7: Nursing staff must have at least one month experience with both fingerstick and continuous glucose monitoring and be registered nurses or certified nursing assistants

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Department of Surgery, Zealand University Hospital

Køge, Køge, Denmark, 4600

Actively Recruiting

2

The Department of Surgery, Odense Univeristy Hospital

Odense, Odense, Denmark, 5000

Actively Recruiting

Loading map...

Research Team

H

Helen Schultz, RN, PhD

CONTACT

K

Karoline Schousboe, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

SEQUENTIAL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here